Therapy News and Research

RSS

Bariatric surgery more effective in controlling hypertension rates in obese patients

Bariatric surgery is more effective in controlling hypertension rates, or high blood pressure, in people with obesity and uncontrolled high blood pressure compared to blood pressure medication alone, according to a study published today in the Journal of the American College of Cardiology.

6 Feb 2024

Single-cell study reveals clues to epigenetic drug response in Myelodysplastic Syndrome

Researchers from the Josep Carreras Leukaemia Research Institute, spearheaded by the Cancer Epigenetics group led by Dr. Manel Esteller, described the effects of chemotherapy at the single cell resolution in the bone marrow of Myelodysplastic Syndrome patients.

6 Feb 2024

Personalized medicine offers hope for millions with inflammatory bowel disease

The prevalence of inflammatory bowel disease (IBD), encompassing ulcerative colitis (UC) and Crohn's disease (CD), is rapidly increasing worldwide, affecting an estimated 6.8 million people.

6 Feb 2024

Expert calls for harm reduction to address drug overdose crisis

With more than 100,000 drug overdose deaths in the United States in one year, communities need more than 'just say no' drug prevention education and abstinence-only addiction treatment to save lives, an expert has warned.

6 Feb 2024

COVID-19's impact on early education: Retrospective study shows decrease in kindergarten readiness

A new study explored associations between school district early Kindergarten Readiness Assessment (KRA) and electronic health records (EHR) data and linked KRA scores with the changes occurring during the COVID-19 pandemic.

6 Feb 2024

Paxlovid enhances treatment options for COVID-19 patients

The design, synthesis, and mechanism of action of Paxlovid.

6 Feb 2024

NIH awards $1.9 million to investigate how complex communities of microbes impact human health

The bacteria and microorganisms that live within the human body - the microbiota - can impact human health, disease risk and even how the body absorbs medications, but the details of these processes are unclear.

5 Feb 2024

MSU scientists unveil a potential game-changer in the fight against glioblastoma

A team of Michigan State University scientists has unveiled a potential game-changer in the fight against glioblastoma, the most common and currently incurable form of brain cancer.

5 Feb 2024

Long-COVID recovery insight: Fatigue and cognitive deficits improve over two years

Study reveals improvements in cognitive deficits and fatigue among long-COVID patients over two years, with specific risk factors like depressive symptoms and old age predicting non-recovery.

5 Feb 2024

Mediterranean and MIND diets boost memory retention in midlife

The Mediterranean and MIND diets are linked to the preservation of episodic and visuospatial working memory in midlife, potentially through dietary fiber and beneficial gut bacteria.

5 Feb 2024

Teenage bullying linked to lower brain glutamate, early psychosis symptoms

Researchers have found that adolescents being bullied by their peers are at greater risk of the early stages of psychotic episodes and in turn experience lower levels of a key neurotransmitter in a part of the brain involved in regulating emotions.

5 Feb 2024

Decoding cancer's spread: Epigenetic switch controls metastasis formation

Scientists from the German Cancer Research Center (DKFZ) and Heidelberg University investigated in mice how spreading tumor cells behave at the site of metastasis: Some tumor cells immediately start to form metastases.

5 Feb 2024

Protein may hold key to restoring treatment response in drug-resistant neuroendocrine prostate cancer

It may be possible to restore drug-resistant neuroendocrine prostate cancer to a state that responds to treatment by depletion of a certain protein in cancer cells.

5 Feb 2024

First gene therapy trial aims to restore hearing in children

The aim of this clinical trial, which has just received approval in France, is to assess the safety and efficacy of a new gene therapy drug in children aged between 6 and 31 months with profound hearing loss.

5 Feb 2024

PI3K/AKT and MEK/ERK pathways targeted in new therapy for docetaxel-resistant prostate cancer

A team of researchers from the Badalona Applied Research Group in Oncology (B·ARGO) and the Urologic Tumours Unit of the Institut Català d'Oncologia (ICO) and the Germans Trias i Pujol Research Institute (IGTP) have found a new therapeutic strategy for patients with a specific subtype of metastatic prostate cancer resistant to standard chemotherapy treatment with docetaxel.

5 Feb 2024

Therapy News and Research

Bariatric surgery more effective in controlling hypertension rates in obese patients

Single-cell study reveals clues to epigenetic drug response in Myelodysplastic Syndrome

Personalized medicine offers hope for millions with inflammatory bowel disease

Expert calls for harm reduction to address drug overdose crisis

COVID-19's impact on early education: Retrospective study shows decrease in kindergarten readiness

Paxlovid enhances treatment options for COVID-19 patients

NIH awards $1.9 million to investigate how complex communities of microbes impact human health

MSU scientists unveil a potential game-changer in the fight against glioblastoma

Long-COVID recovery insight: Fatigue and cognitive deficits improve over two years

Mediterranean and MIND diets boost memory retention in midlife

Teenage bullying linked to lower brain glutamate, early psychosis symptoms

Decoding cancer's spread: Epigenetic switch controls metastasis formation

Protein may hold key to restoring treatment response in drug-resistant neuroendocrine prostate cancer

First gene therapy trial aims to restore hearing in children

PI3K/AKT and MEK/ERK pathways targeted in new therapy for docetaxel-resistant prostate cancer

The power of precision oncology: closing the cancer care gap

Revvity showcases cutting-edge solutions at SLAS2024

New method helps to reliably distinguish surgical meshes from normal bodily tissue

Black garlic may have anti-cancer and anti-inflammatory properties

New study reveals cefoxitin as effective first-line treatment for intraamniotic infections

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News